Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rehli

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Cell Reports|July 31, 2024
STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemiaAlexander Fischer, Benjamín Hernández-Rodríguez, Roger Mulet-Lazaro, et al.
Nature Communications|April 10, 2019
Rbpj expression in regulatory T cells is critical for restraining T<sub>H</sub>2 responsesMichael Delacher, Christian Schmidl, Yonatan Herzig, et al.
Molecular Metabolism|February 10, 2025
ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerancePhilipp Stüve, Gloria J Godoy, Fernando N Ferreyra, et al.
Cell Reports. Medicine|October 26, 2023
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomasEnrique Blanco-Carmona, Ashwin Narayanan, Inmaculada Hernandez, et al.
Blood|May 5, 2025
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHDKatharina Marie Habenicht, Jana Wanzek, Anna Bootz, et al.
Genome Medicine|June 20, 2014
Early aberrant DNA methylation events in a mouse model of acute myeloid leukemiaMiriam Sonnet, Rainer Claus, Natalia Becker, et al.
Nature Communications|July 7, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemiaRoger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, et al.
Haematologica|January 18, 2024
D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cellsKathrin Hammon, Kathrin Renner, Michael Althammer, et al.
Blood|March 12, 2016
An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiationRoberto Avellino, Marije Havermans, Claudia Erpelinck, et al.
Immunity|January 12, 2020
Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATFMichael Delacher, Charles D Imbusch, Agnes Hotz-Wagenblatt, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Cell Reports|July 31, 2024
STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemiaAlexander Fischer, Benjamín Hernández-Rodríguez, Roger Mulet-Lazaro, et al.
Nature Communications|April 10, 2019
Rbpj expression in regulatory T cells is critical for restraining T<sub>H</sub>2 responsesMichael Delacher, Christian Schmidl, Yonatan Herzig, et al.
Molecular Metabolism|February 10, 2025
ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerancePhilipp Stüve, Gloria J Godoy, Fernando N Ferreyra, et al.
Cell Reports. Medicine|October 26, 2023
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomasEnrique Blanco-Carmona, Ashwin Narayanan, Inmaculada Hernandez, et al.
Blood|May 5, 2025
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHDKatharina Marie Habenicht, Jana Wanzek, Anna Bootz, et al.
Genome Medicine|June 20, 2014
Early aberrant DNA methylation events in a mouse model of acute myeloid leukemiaMiriam Sonnet, Rainer Claus, Natalia Becker, et al.
Nature Communications|July 7, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemiaRoger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, et al.
Haematologica|January 18, 2024
D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cellsKathrin Hammon, Kathrin Renner, Michael Althammer, et al.
Blood|March 12, 2016
An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiationRoberto Avellino, Marije Havermans, Claudia Erpelinck, et al.
Immunity|January 12, 2020
Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATFMichael Delacher, Charles D Imbusch, Agnes Hotz-Wagenblatt, et al.
Pageof 12